Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical has signed an agreement with RPG life science to divest seven prescription brands in India, owned by Sun Pharmaceutical Industries and its subsidiary, for a consideration of Rs 41 crore. This divestment is subject to receipt of Competition Commission of India’s (CCI) approval.

The seven divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices.